For all media enquiries please contact Katarina Janerud, 
Communications Manager: 

Tel: +46 8 440 50 50 
Direct: +46 8 440 50 69 
Mobile: +46 709 69 69 99
Fax. +46 8 611 79 98 
e-mail:
katarina.janerud@nordiccapital.com  

ConvaTec prevails in patent case brought by Smith & Nephew

Dec 19, 2012

ConvaTec, a world-leading developer of innovative medical technologies, is pleased to announce that the Court of Appeal in the Royal Courts of Justice in the United Kingdom has upheld a previous court's decision validating ConvaTec's  patent for its innovative design and manufacturing process for producing silver wound dressings.

This mirrors a similar decision in the European Patent Office last month that ConvaTec's patents for silver wound dressings around Europe are valid.

ConvaTec's AQUACEL® Ag wound dressings include ionic silver, which kills harmful bacteria.

"We were pleased with the original court's decision to uphold our patent and are gratified with this new ruling against Smith & Nephew's appeal," said Ken Berger, CEO. "This ruling recognizes ConvaTec's scientific innovation in the wound care area and the need to protect such work." 

ConvaTec's AQUACEL® wound dressings have a gel-forming wound contact layer that promotes healing and protects against infection. The AQUACEL® Ag wound dressing adds ionic silver for even more protection against harmful bacteria.

About ConvaTec
ConvaTec is a leading developer and marketer of innovative medical technologies that have helped improve the lives of millions of people worldwide.  With four key focus areas - Ostomy Care, Wound Therapeutics, Continence and Critical Care, and Infusion Devices - ConvaTec products support healthcare professionals from the hospital to the community health setting.  The company has world class manufacturing on nearly every continent and a production network of 12 plants in nine countries. For more information, please visit www.convatec.com

About Nordic Capital Private Equity Funds

Since the start in 1989, Nordic Capital Private Equity Funds have invested in large and medium sized companies, primarily in Northern Europe. Through committed ownership and by targeting strategic development and operational improvements, Nordic Capital creates value in its investments. The funds invest in companies in Northern Europe and in selected investment opportunities internationally. They are based in Jersey, Channel Islands, and are advised by the NC Advisory companies in Sweden, Denmark, Finland, Norway, Germany and the UK. Additional information about Nordic Capital is available through its corporate website, www.nordiccapital.com

Back to news listings >